Jenny Zilberberg

Jenny Zilberberg

Company: Imvax Inc.

Job title: Senior Principal Scientist


Insights to Assist Finding the Right Vaccine Platforms 12:00 pm

Developing individualised therapeutic cancer vaccines against neoantigens arising from somatic gene mutations in malignant cells Demonstrating induction of strong cancer-specific immune responses which lead to clinical responses in several patientsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.